Ever sat through a meeting that felt more like a game of 'Who Said What?' than useful information? That’s exactly what many pregnant and trying-to-conceive folks experienced during the FDA’s recent two-hour session on SSRIs (Selective Serotonin Reuptake Inhibitors) and pregnancy. Spoiler alert: it was confusing — and frankly, some might say a bit misleading.